Search
clinical dementia rating - sum of boxes (CDR-SB)
Interpretation:
- range 0-18, higher scores indicate greater impairment
- score of 3.2 is consistent with early Alzheimer's disease
General
clinical dementia rating scale (CDR)
References
- George J
Alzheimer's Drug Slows Decline, Trial Data Show.
Lecanemab met primary and secondary endpoints, but was associated with adverse events.
MedPage Today November 30, 2022
https://www.medpagetoday.com/neurology/alzheimersdisease/101972
- van Dyck CH, Swanson CJ, Aisen P
Lecanemab in Early Alzheimer's Disease.
N Engl J Med 2022. Nov 29.
PMID: 36449413
https://www.nejm.org/doi/full/10.1056/NEJMoa2212948